BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 34098555)

  • 41. Temporal trends of COVID-19 related in-hospital mortality and demographics in Switzerland - a retrospective single centre cohort study.
    Diebold M; Martinez AE; Adam KM; Bassetti S; Osthoff M; Kassi E; Steiger J; Pargger H; Siegemund M; Battegay M; Khanna N; Schaub S; Wesch C; Dickenmann M; Weisser M
    Swiss Med Wkly; 2021 Jul; 151():w20572. PubMed ID: 34324697
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical outcomes of hospitalized COVID-19 patients with renal injury: a multi-hospital observational study from Wuhan.
    Chen K; Lei Y; He Y; Xiao F; Yu Y; Lai X; Liu Y; Wang J; Dai H
    Sci Rep; 2021 Jul; 11(1):15205. PubMed ID: 34312430
    [TBL] [Abstract][Full Text] [Related]  

  • 43. COVID-19 incidence and mortality in non-dialysis chronic kidney disease patients.
    Gibertoni D; Reno C; Rucci P; Fantini MP; Buscaroli A; Mosconi G; Rigotti A; Giudicissi A; Mambelli E; Righini M; Zambianchi L; Santoro A; Bravi F; Altini M
    PLoS One; 2021; 16(7):e0254525. PubMed ID: 34242368
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Characteristics and outcomes of hospitalised older patients with chronic kidney disease and COVID-19: A multicenter nationwide controlled study.
    Ozturk S; Turgutalp K; Arici M; Gok M; Islam M; Altiparmak MR; Aydin Z; Doner B; Eren N; Sengul E; Karadag S; Ozler TE; Dheir H; Pembegul I; Guven Taymez D; Sahin G; Bakirdogen S; Dolarslan ME; Soypacaci Z; Hur E; Kara E; Basturk T; Ogutmen MB; Gorgulu N; Sahin I; Ayli MD; Tuglular ZS; Sahin G; Tokgoz B; Tonbul HZ; Yildiz A; Sezer S; Odabas AR; Ates K
    Int J Clin Pract; 2021 Sep; 75(9):e14428. PubMed ID: 34085352
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The role of uric acid in chronic kidney disease patients.
    Hsieh YP; Chang CC; Yang Y; Wen YK; Chiu PF; Lin CC
    Nephrology (Carlton); 2017 Jun; 22(6):441-448. PubMed ID: 26610276
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Impact of Renin-Angiotensin System Blockade on Renal Outcomes and Mortality in Pre-Dialysis Patients with Advanced Chronic Kidney Disease.
    Oh YJ; Kim SM; Shin BC; Kim HL; Chung JH; Kim AJ; Ro H; Chang JH; Lee HH; Chung W; Lee C; Jung JY
    PLoS One; 2017; 12(1):e0170874. PubMed ID: 28122064
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cardiovascular comorbidities as predictors for severe COVID-19 infection or death.
    Phelps M; Christensen DM; Gerds T; Fosbøl E; Torp-Pedersen C; Schou M; Køber L; Kragholm K; Andersson C; Biering-Sørensen T; Christensen HC; Andersen MP; Gislason G
    Eur Heart J Qual Care Clin Outcomes; 2021 Mar; 7(2):172-180. PubMed ID: 33107909
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Short- and long-term outcomes after non-severe acute kidney injury.
    Arias-Cabrales C; Rodríguez E; Bermejo S; Sierra A; Burballa C; Barrios C; Soler MJ; Pascual J
    Clin Exp Nephrol; 2018 Feb; 22(1):61-67. PubMed ID: 28551821
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Rhabdomyolysis in Patients Hospitalized With COVID-19 Infection: Five Case Series.
    Khosla SG; Nylen ES; Khosla R
    J Investig Med High Impact Case Rep; 2020; 8():2324709620984603. PubMed ID: 33371733
    [TBL] [Abstract][Full Text] [Related]  

  • 50. COVID-19 in Patients with CKD in New York City.
    Akchurin O; Meza K; Biswas S; Greenbaum M; Licona-Freudenstein AP; Goyal P; Choi JJ; Choi ME
    Kidney360; 2021 Jan; 2(1):63-70. PubMed ID: 33629075
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hospitalization and 1-year all-cause mortality in type 2 diabetic patients with chronic kidney disease at Stages 1 and 2: Effect of mild anemia.
    Nseir W; Artul S; Nasrallah N; Mograbi J; Mahamid M
    J Diabetes; 2016 Jul; 8(4):502-7. PubMed ID: 26040706
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Diabetes retinopathy is a poor predictor for renal and cardiovascular outcomes in comparison with hypertensive retinopathy in patients with chronic kidney disease.
    Hwang HS; Choi YA; Kim SY; Cho WK; Nam Y; Kim SJ; Yoon HE; Chang YK; Shin SJ; Yang CW; Kim SY
    Diabetes Res Clin Pract; 2015 Aug; 109(2):312-8. PubMed ID: 26008724
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A survey on acute kidney injury in severely and critically ill COVID-19 patients without chronic kidney disease.
    Yu Y; Ge H; Wang X; Huang Z; Chen L; Han Y; Jiang D; Tao L; Zhou Q; Peng Z; Xiao X
    Ann Palliat Med; 2021 Jun; 10(6):6198-6207. PubMed ID: 34044555
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Burden of kidney disease on the discrepancy between reasons for hospital admission and death: An observational cohort study.
    Mandai S; Ando F; Mori T; Susa K; Iimori S; Naito S; Sohara E; Uchida S; Fushimi K; Rai T
    PLoS One; 2021; 16(11):e0258846. PubMed ID: 34731197
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prevalence of comorbidity in Chinese patients with COVID-19: systematic review and meta-analysis of risk factors.
    Yin T; Li Y; Ying Y; Luo Z
    BMC Infect Dis; 2021 Feb; 21(1):200. PubMed ID: 33618678
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Effect of hyperkalemia and RAASi nonadherence on patients affected by heart failure or chronic kidney disease].
    Degli Esposti L; Perrone V; Giacomini E; Sangiorgi D; Alessandrini D; Santoro A
    G Ital Nefrol; 2019 Sep; 36(5):. PubMed ID: 31580544
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Outcomes of stage 1-5 chronic kidney disease in Mainland China.
    Lai X; Zhang AH; Chen SY; He L; Su CY; Fan MH; Wang T
    Ren Fail; 2014 May; 36(4):520-5. PubMed ID: 24456114
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hypertension in Patients Hospitalized with COVID-19 in Wuhan, China.
    Zhang Y; Sha T; Wu F; Hu H; Chen Z; Li H; Han J; Song W; Huang Q; Zeng Z
    Int Heart J; 2021 Mar; 62(2):337-343. PubMed ID: 33678794
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparative analysis between the use of renin-angiotensin system antagonists and clinical outcomes of hospitalized patients with COVID-19 respiratory infection.
    Martínez-Del Río J; Piqueras-Flores J; Nieto-Sandoval Martín de la Sierra P; Negreira-Caamaño M; Águila-Gordo D; Mateo-Gómez C; Salas-Bravo D; Rodríguez-Martínez M
    Med Clin (Barc); 2020 Dec; 155(11):473-481. PubMed ID: 32782110
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The use of renin-angiotensin-aldosterone system (RAAS) inhibitors is associated with a lower risk of mortality in hypertensive COVID-19 patients: A systematic review and meta-analysis.
    Wang Y; Chen B; Li Y; Zhang L; Wang Y; Yang S; Xiao X; Qin Q
    J Med Virol; 2021 Mar; 93(3):1370-1377. PubMed ID: 33095513
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.